$BMY · OPTIONS PERFORMANCE
Bristol-Myers Squibb CompanyEarnings & option results
← All results
Bristol-Myers Squibb Company options
EXPLORE COMPANY RESEARCH
Bristol-Myers Squibb: the full stock picture
Earnings history, financials, price action and peer comparisons — all below.EXPLORE THE COMPANY
Bristol-Myers Squibb (BMY)
Explore earnings, price action, financials and industry comparisons.
- Symbol
- BMY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Instrument type
- EQUITY
Profile information from our saved company catalog. This is not a live quote or confirmation of current listing status.
EARNINGS & COMPANY RESEARCH
View in calendar ↗BMY earnings, valuation & price action
NEXT EXPECTED REPORTFeb 4 2027Time unconfirmed · ET
EPS ESTIMATE1.50
REVENUE ESTIMATE12.66B
Expected dates may change. Estimates use the source’s reporting currency. Quotes and research are snapshots, not live prices.
COMPANY RESEARCH · Healthcare
Bristol-Myers Squibb Company BMY
Drug Manufacturers - General · Updated 11/10/2026
Adjusted closing price · USD62.14 Nov 9
Price50-day average200-day average+39.2% in view
VALUATION & EXPECTATIONS
Trailing P/E13.7×
Forward P/E9.6×
Trailing P/S2.5×
Forward P/S2.5×
EPS beat rate100%
Revenue beat rate100%
Positive window63%
EPS beats: 8 of 8 comparable reports. Positive price windows: 5 of 8.
Market caps may be up to 14 days old; prices up to seven days old; ratios and analyst estimates up to fourteen days old. Forward multiples use consensus for the fiscal year ending 2026-12-31, not the next 12 months. Negative or unavailable earnings multiples show “N/A”. Forward ADR multiples are omitted when the currency/share basis is not reconciled.
50-day average61.96
200-day average59.16
RSI (14)52
20-day range56.67 – 64.19
Relative volume0.6×
1-year change+39.2%
| Report date | EPS estimate | EPS actual | Surprise | Result | Revenue actual | Price window* | 5 sessions* |
|---|---|---|---|---|---|---|---|
| Oct 29 2026 | 1.10 | 1.35 | +22.7% | Beat | 13.07B | +3.2% | +4.2% |
| Jul 30 2026 | 1.60 | 2.04 | +27.5% | Beat | 12.97B | +3.5% | +1.7% |
| Apr 30 2026 | 1.42 | 1.58 | +11.3% | Beat | 11.49B | +1.1% | -2.3% |
| Feb 5 2026 | 1.23 | 1.26 | +2.4% | Beat | 12.5B | +7.6% | +3.9% |
| Oct 30 2025 | 1.52 | 1.63 | +7.2% | Beat | 12.22B | +8.1% | +9.4% |
| Jul 31 2025 | 1.09 | 1.46 | +33.9% | Beat | 12.27B | -3.8% | -1.3% |
| Apr 24 2025 | 1.49 | 1.80 | +20.8% | Beat | 11.2B | -1.3% | +2.2% |
| Feb 6 2025 | 1.47 | 1.67 | +13.6% | Beat | 12.34B | -4.8% | -6.3% |
*Adjusted close before the report date to the first (or fifth) trading close after it. This window can span two sessions and is not an isolated earnings-day return. Figures may be revised by the provider.
Smart Money activity
Recent insider and politician transactions, and disclosed fund positions for BMY.
Get Pro to see what insiders are doing ahead of earnings.
Explore insider trades, fund holdings and politician activity with an active Pro membership.
Checking membership…
Bristol-Myers Squibb financials
Revenue, earnings, cash flow and financial strength in one view.
Reporting currency unconfirmed.
Revenue
Net income
Gross profit
Operating income
EBITDA
Operating cash flow
Capital expenditure
Cash
Total assets
Total liabilities
Shareholder equity
Total debt
Net profit margin
Gross margin
Short interest: days to cover
How to read these financial metrics
Figures use the app’s saved statements for the displayed period, not a trailing-year total. Margins divide profit by revenue; quick ratio uses current assets less inventory divided by current liabilities. Compare dates and currencies before comparing companies.
Bristol-Myers Squibb event catalysts
Company earnings and scheduled market events that may change expectations.
2027-02-04
BMY earnings
Watch reported results, management’s outlook and the share-price reaction.
See earnings expectations ↑MSCI · index review announcement
Review official additions, deletions and weight changes; release time is not specified here.
Release schedule ↗ScheduledInitial jobless claims
Use the multiweek trend to distinguish normal volatility from a sustained increase in layoffs.
Release schedule ↗ScheduledPPI inflation
Watch the surprise versus expectations and implications for margins and interest rates.
Release schedule ↗ScheduledRussell · preliminary additions/deletions
Check the official lists. Preliminary changes can be revised.
Release schedule ↗Scheduled13F filing deadline · Q3 holdings
Filings may arrive earlier and positions can have changed. A filing is not a new trade or a guarantee of buying pressure.
Release schedule ↗ScheduledRetail sales
Look beyond autos and gasoline; stronger spending can help earnings but also keep yields elevated.
Release schedule ↗ScheduledIndustrial production
Check factory output and utilization for changes in cyclical demand.
Release schedule ↗ScheduledHousing starts & building permits
Housing is sensitive to interest rates. Watch permits for indications of future building activity.
Release schedule ↗ScheduledDates use U.S. Eastern time and can change. Calendar events provide context; they do not determine the direction of a stock move.
Compare BMY with its peers
Drug Manufacturers - General · Compare valuation, financial strength and price performance.
Companies with valuation data7
Peer median positive P/E27.5×
BMY P/E13.7×
| Company | Price | Market cap | P/E | Forward P/E | P/S | Forward P/S |
|---|---|---|---|---|---|---|
| BMYBristol-Myers Squibb2026-11-09 · USD | 62.14 | 126.14B | 13.7× | 9.6× | 2.5× | 2.5× |
| ABBVAbbVie Inc.2026-11-10 · USD | 293.89 | 510.59B | 49.6× | 21.1× | 7.7× | 7.6× |
| AMGNAmgen Inc.2026-11-10 · USD | 465.23 | 258.68B | 27.5× | 20.1× | 6.6× | 6.6× |
| AZNAstraZeneca PLC2026-11-10 · USD | 186.76 | 289.36B | 26.1× | 18.2× | 4.6× | 4.6× |
| GILDGilead Sciences, Inc.2026-11-10 · USD | 169.88 | 216.11B | 7.0× | 6.9× | ||
| GSKGSK plc2026-11-10 · USD | 51.31 | 103.61B | 17.5× | 2.3× | ||
| JNJJohnson & Johnson2026-11-10 · USD | 280.78 | 663.03B | 41.8× | 25.3× | 6.7× | 6.6× |
BMY13.7×
ABBV49.6×
AMGN27.5×
AZN26.1×
GSK17.5×
JNJ41.8×
The peer median excludes the selected stock and is based on 5 available positive multiples. P/E median excludes negative or missing earnings multiples. Peer reports can have different fiscal periods and currencies; values are not currency-converted.
Explore BMY alongside its peers
Drug Manufacturers - General · 15 companies · Cached market data
Comparison
Compare companies
Tap a bubble to inspect a company, then × to hide it. Undo restores the last company hidden. Bubble area reflects market cap, with a minimum size for visibility.
BMYBristol-Myers Squibb Company
Market cap: 126.14B
Price / sales: 2.5×
13 of 15 companies have both plotted values.
P/S distribution
Trailing price-to-sales multiples · 13 companies
Median P/S5.4×
Middle 50%2.7× to 6.7×
BMY P/S2.5×
BMY
1.9×8.1×
Tap a bar to see the companies in that P/S range. BMY has a higher P/S than 15% of this group.
2 companies excluded from P/S statistics because sales are non-positive or the saved multiple is missing. Statistics include all valid positive values, including those outside the focused chart range.
Companies
Showing 8 of 15 matching companies · Largest market cap first
- Market cap 1.33TP/E 45.7×P/S 15.4×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 663.03BP/E 41.8×P/S 6.7×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 510.59BP/E 49.6×P/S 7.7×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 365.7BP/E 151.3×P/S 5.4×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 305.05BP/E 30.9×P/S 5.5×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 289.36BP/E 26.1×P/S 4.6×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 258.68BP/E 27.5×P/S 6.6×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
- Market cap 216.11BP/E P/S 7.0×Forward P/E Forward P/S Price snapshot: 2026-11-10↗
Explore industries
Open an industry for its comparison, valuation and companies.
- Drug Manufacturers - General15 companies · Median P/E 29.2×P/E based on 12 saved positive multiples
- Advertising Agencies7 companies · Median P/E 15.2×P/E based on 2 saved positive multiples
- Aerospace & Defense28 companies · Median P/E 24.1×P/E based on 11 saved positive multiples
- Agricultural Inputs2 companies · Median P/E 53.0×P/E based on 1 saved positive multiple
- Airlines8 companies
- Apparel Manufacturing2 companies
- Apparel Retail6 companies · Median P/E 25.7×P/E based on 3 saved positive multiples
- Asset Management14 companies · Median P/E 30.4×P/E based on 4 saved positive multiples
U.S.-listed companies from the app’s catalog. Medians use saved positive P/E values; coverage and snapshot dates vary.
How this comparison works
Uses the saved companies from the same industry and listing market, including BMY, ordered by cached market cap. Company snapshots can have different dates; the web cache may cover fewer metrics and periods than the app.
Periods end at each company’s dated price snapshot. Change compares the latest saved observation with one at or before the selected period’s start. A daily price change uses consecutive saved sessions. Financial data updates quarterly, so short periods may show no change. Missing history and zero starting values are excluded; a negative starting value uses its absolute value as the denominator.
Metrics use saved ratios and percentages. Market caps use the listing market’s reporting currency; underlying financial statements may use different currencies. Circle sizes have a minimum for touch visibility, and an outlined circle indicates a missing market cap. These comparisons describe data, not recommendations or price predictions.
INDUSTRY COMPARISON
BMY industry peers
Drug Manufacturers - General · Oct 16, 2026 · Closing-price performance
Compare BMY with 7 other stocks in the available heatmap coverage.